Physician

Michael Allen Magee, M.D.

According to 2025 Medicare claims, Michael Magee, M.D. (NPI: 1134120868) practices ophthalmology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is SOUTHEASTERN RETINA ASSOCIATES, P.C. (NPI: 1932370145; TIN: 621094813) and primary practice location at 24210-3202.

Magee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 415 traditional Medicare patients, billed 12,670 HCPCS/CPT codes, and received $1,269,812 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 332 prescription claims across 168 beneficiaries totaling $19,249 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). Open Payments data shows 10 records totaling $330. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $204,398 to $1,269,812. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	703	3,579	$204,398
2016	751	3,885	$210,533
2017	716	3,713	$196,065
2018	686	3,667	$203,751
2019	558	3,028	$177,269
2020	421	2,846	$160,827
2021	398	2,347	$114,555
2022	365	2,023	$91,891
2023	487	5,313	$504,397
2024	415	12,670	$1,269,812

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	83	205	$13,165
2016	88	229	$17,123
2017	90	230	$15,826
2018	117	305	$16,137
2019	107	319	$21,131
2020	76	232	$16,458
2021	80	220	$16,759
2022	49	185	$17,878
2023	133	295	$20,514
2024	168	332	$19,249

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	130	130	$115
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	127	127	$110
67028	Injection of drug into eye	187	787	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	126	160	$63
92134	Imaging of retina	393	1,093	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	113	2,453	$5,332
Prednisolone Acetate	Prednisolone Acetate	48	2,144	$2,874
Atropine Sulfate	Atropine Sulfate	15	785	$710
Ketorolac Tromethamine	Ketorolac Tromethamine	19	721	$554
Brimonidine Tartrate	Brimonidine Tartrate	29	1,799	$405

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$330	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Allen Magee, M.D.?

Tedicare shows public-source Medicare data for Michael Allen Magee, M.D. (NPI 1134120868), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Allen Magee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Allen Magee, M.D.?

Michael Allen Magee, M.D. is linked to SOUTHEASTERN RETINA ASSOCIATES, P.C. (billing NPI 1932370145) in the available physician profile data.

Does Michael Allen Magee, M.D. have Open Payments data?

Michael Allen Magee, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.